Mitochondrial Cx43 hemichannels contribute to mitochondrial calcium entry and cell death in the heart.
Ashish Kumar GadicherlaNan WangMarco BulicEsperanza Agullo-PascualAlessio LissoniMaarten De SmetMario DelmarGeert BultynckDmitri V KryskoAmadou CamaraKlaus-Dieter SchlüterRainer SchulzWai-Meng KwokLuc LeybaertPublished in: Basic research in cardiology (2017)
Mitochondrial connexin 43 (Cx43) plays a key role in cardiac cytoprotection caused by repeated exposure to short periods of non-lethal ischemia/reperfusion, a condition known as ischemic preconditioning. Cx43 also forms calcium (Ca2+)-permeable hemichannels that may potentially lead to mitochondrial Ca2+ overload and cell death. Here, we studied the role of Cx43 in facilitating mitochondrial Ca2+ entry and investigated its downstream consequences. To that purpose, we used various connexin-targeting peptides interacting with extracellular (Gap26) and intracellular (Gap19, RRNYRRNY) Cx43 domains, and tested their effect on mitochondrial dye- and Ca2+-uptake, electrophysiological properties of plasmalemmal and mitochondrial Cx43 channels, and cell injury/cell death. Our results in isolated mice cardiac subsarcolemmal mitochondria indicate that Cx43 forms hemichannels that contribute to Ca2+ entry and may trigger permeability transition and cell injury/death. RRNYRRNY displayed the strongest effects in all assays and inhibited plasma membrane as well as mitochondrial Cx43 hemichannels. RRNYRRNY also strongly reduced the infarct size in ex vivo cardiac ischemia-reperfusion studies. These results indicate that Cx43 contributes to mitochondrial Ca2+ homeostasis and is involved in triggering cell injury/death pathways that can be inhibited by RRNYRRNY peptide.
Keyphrases
- cell death
- oxidative stress
- single cell
- left ventricular
- cell therapy
- heart failure
- ischemia reperfusion injury
- metabolic syndrome
- signaling pathway
- acute myocardial infarction
- coronary artery disease
- acute coronary syndrome
- endothelial cells
- high throughput
- atrial fibrillation
- subarachnoid hemorrhage
- mass spectrometry
- cancer therapy
- bone marrow
- drug delivery
- high speed
- atomic force microscopy
- case control